Multidose Safety and Tolerability Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKACE™)

Clinical trial NCT00777296 · COMPLETED

Trial details

NCT number: NCT00777296
Sponsor: Insmed Incorporated
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2007-02-22
Primary completion: 2008-02-27
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.